Showing results (511-520 of 553) with videos related to
Sort By:
Pageof 56
Movement Disorders : Official Journal of the Movement Disorder Society|April 21, 2022
The Movement Disorder Society Criteria for the Diagnosis of Multiple System AtrophyGregor K Wenning, Iva Stankovic, Luca Vignatelli, et al.The Lancet. Neurology|July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.Science Translational Medicine|February 21, 2012
Phosphorylated α-synuclein in Parkinson's diseaseYu Wang, Min Shi, Kathryn A Chung, et al.Cell Stem Cell|March 12, 2013
Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expressionPeter Reinhardt, Benjamin Schmid, Lena F Burbulla, et al.Nature Communications|November 25, 2020
Common diseases alter the physiological age-related blood microRNA profileTobias Fehlmann, Benoit Lehallier, Nicholas Schaum, et al.Journal of Parkinson'S Disease|June 4, 2025
Tackling gender in progressive supranuclear palsy: Male patients present more apathyLan Ye, Stephan Greten, Ida Wilkens, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 2021
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PDGBAStefanie Lerche, Claudia Schulte, Isabel Wurster, et al.Journal of Parkinson'S Disease|March 8, 2021
Parkinson's Disease Subtypes: Critical Appraisal and RecommendationsTiago A Mestre, Seyed-Mohammad Fereshtehnejad, Daniela Berg, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Charles H Adler, Bastiaan R Bloem, et al.Pageof 56